Kuljit Singh
Psychiatry · West Nyack, NYNPI 1548236854
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.7% of the total across 234 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 19 manufacturers, the largest accounting for just 21.8% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $1,965, 3.9 times the $499 reported in 2019. Among psychiatry clinicians in NY with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 234 payments — averaging $34.77 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- Axsome Therapeutics, Inc.$2K
- Alkermes, Inc.$1K
- Neurocrine Biosciences, Inc.$970
- Otsuka America Pharmaceutical, Inc.$955
- Sunovion Pharmaceuticals Inc.$407
- plus $1K from 13 others
What the payments were for
- Food & beverage$8,108100%
- Education$270%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 47 | $1,770 |
| Axsome Therapeutics, Inc. | 43 | $1,614 |
| Alkermes, Inc. | 41 | $1,174 |
| Neurocrine Biosciences, Inc. | 26 | $970 |
| Otsuka America Pharmaceutical, Inc. | 12 | $955 |
| Sunovion Pharmaceuticals Inc. | 18 | $407 |
| E.r. Squibb & Sons, L.L.C. | 16 | $334 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 11 | $312 |
| Corium, LLC | 4 | $170 |
| Johnson & Johnson | 3 | $94 |
| Vanda Pharmaceuticals Inc. | 2 | $66 |
| Almatica Pharma LLC | 2 | $61 |
| Supernus Pharmaceuticals, Inc. | 2 | $54 |
| Bioxcel Therapeutics, Inc. | 2 | $48 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $24 |
| Orexo US, Inc. | 1 | $23 |
| Collegium Pharmaceutical, Inc. | 1 | $22 |
| Jazz Pharmaceuticals Inc. | 1 | $20 |
| Lundbeck LLC | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- VRAYLAR$1,351
- LYBALVI$925
- Auvelity$622
- REXULTI$610
- INGREZZA$591
- ARISTADA$499
- ABILIFY MAINTENA$250
- CAPLYTA$129
- ABILIFY ASIMTUFII$125
- COBENFY$125
- VIVITROL$125
- ARISTADA INITIO$125
- Azstarys$125
- LATUDA$121
How this compares
$8,136 in reported general payments places this provider in the 90th percentile of 3,713 psychiatry providers in New York.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Duloxetine Hcl | 20 | $233 |
| Clonazepam | 11 | $10 |
Paid to pharmacies, not to this prescriber.
Other psychiatry in West Nyack
- Balveen SinghWest Nyack$222K
- Leslie CitromePomona$5.7M
- Sanjay GuptaCheektowaga$1.9M
- Richard PriceMonsey$1.7M
- Adam AshtonAmherst$1.6M
- Christoph CorrellGlen Oaks$1.5M
- Manish ZinzuvadiaNew York$1.3M
- George KruseBronx$1.2M
- Jianping ChenNew York$1.2M
- Horacio CapoteAmherst$1.1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.